Navigation Links
Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
Date:10/7/2008

SAN CARLOS, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) President and CEO Howard W. Robin is scheduled to present at the upcoming Natixis Bleichroeder Second Annual Hidden Gems Conference in New York at the Waldorf-Astoria Hotel on Monday, October 13, 2008 at 2:30 p.m. ET.

The presentation will be accessible via Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until October 27, 2008.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development technology platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled eight approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

CONTACT:

Stephan Herrera

Nektar Therapeutics

1-415-488-7699

sherrera@nektar.com


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. West Concludes Agreement with Nektar
11. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... ... the first-ever recipient of the National Academy of Sciences Prize in Food and ... and nutrition. , The annual National Academy of Sciences (NAS) Prize in Food ...
(Date:1/24/2017)... YORK , Jan. 23, 2017  Today, the ... announce they have funded an important study that could ... prevent the onset of Alzheimer,s disease. This groundbreaking research ... Rockefeller University, led by Nobel Laureate Dr. Paul ... for Alzheimer,s disease. Fisher Center scientists have ...
(Date:1/23/2017)... - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) ... Zealand based Phase 1 trial with severe ... in reducing inflamed protein biomarkers in patients with severe ... that this is the first time in medical history ... made between epigenetic regulation and its potential for positive ...
(Date:1/23/2017)... ... January 23, 2017 , ... CallTower is proud to ... Product of the Year Award winner for 2017. , For three consecutive years, ... solutions. In 2016, CallTower was awarded with the hosted VoIP Excellence award and in ...
Breaking Biology Technology:
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017 /PRNewswire/ ... in performance biometric sensor technology, today announced the ... Benchmark™ sensor systems, the highly-accurate biometric sensor ... ® biometric technology, experience and expertise. The ... of Benchmark designed specifically for hearables, and Benchmark ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/15/2016)... Germany , December 15, 2016 ... provider, today announced an agreement with NuData Security, an ... forces. The partnership will enable clients to focus on good ... local data protection regulation. ... In order to provide a one-stop fraud ...
Breaking Biology News(10 mins):